Rapid diagnostic testing for influenza, offered by distributors like McKesson, provides clinicians with timely information to guide patient care. These tests detect viral antigens in respiratory specimens, delivering results within minutes. For example, a nasal swab can be analyzed at the point of care, allowing for immediate diagnosis and treatment decisions.
Prompt and accurate diagnoses are crucial for effective influenza management. This enables timely initiation of antiviral therapy, if appropriate, which can reduce symptom severity and duration. Rapid testing also facilitates informed decisions about isolation precautions, helping to limit the spread of infection within healthcare settings and the community. Historically, influenza diagnosis relied on symptom presentation and viral culture, a time-consuming process. Rapid diagnostic tests represent a significant advancement in influenza management, offering substantial benefits for both patients and public health.
